Dibenzylpiperazine
| DBZP | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 266.4 g/mol [1] |
| Predicted LogP | 3.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H22N2 [1] |
| IUPAC name | 1,4-dibenzylpiperazine [1] |
| SMILES | C1CN(CCN1CC2=CC=CC=C2)CC3=CC=CC=C3 [1] |
| InChI | InChI=1S/C18H22N2/c1-3-7-17(8-4-1)15-19-11-13-20(14-12-19)16-18-9-5-2-6-10-18/h1-10H,11-16H2 [1] |
| InChIKey | YPUGLZQRXQQCSX-UHFFFAOYSA-N [1] |
Dibenzylpiperazine (also known as 1,4-Dibenzylpiperazine, 1034-11-3, Dibenzylpiperazine, Piperazine, 1,4-bis(phenylmethyl)-, N,N'-Dibenzylpiperazine, J503.930D, 616774W5JF, Dtxsid10899765, DBZP or Dtxcid301328492) is a byproduct substance of the benzylpiperazine class.
Chemistry
Stereochemistry []
Dibenzylpiperazine is a achiral mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 200601, 1,4-Dibenzylpiperazine. Accessed March 16, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/200601
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dibenzylpiperazine. UNII: 616774W5JF. Global Substance Registration System. Accessed March 16, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/616774W5JF